Active Ingredient: BRINCIDOFOVIR
Proprietary Name: TEMBEXA
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 10MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N214460
Product Number: 001
Approval Date: Jun 4, 2021
Applicant Holder Full Name: EMERGENT BIODEFENSE OPERATIONS LANSING LLC
Marketing Status:
Prescription
Patent and Exclusivity Information